Immunosuppressive Drugs Committee
-
Last Updated: Thursday, 03 September 2020 10:15

|
Chair
Stein Bergan Oslo, Norway
|
Contact Us Scientific Committees Immunosuppressive Drugs Committee
|
 |
Vice-Chair
Satohiro Masuda Chiba, Japan
|
Background & Purpose of the Committee
- To provide evidence-based recommendations for TDM of immunosuppressive agents.
- To promote the knowledge and understanding of immunosuppressive drug analysis and interpretation of results.
- To enhance communication between scientists and physicians of all disciplines involved in TDM of immunosuppressive drugs.
- To encourage the effective application of TDM in transplant medicine, with the aim of optimizing clinical drug use and maximizing the clinical and economic benefits.
Activities Planned/Committee Initiatives Currently in Progress
- Preparation of a new consensus paper; entitled Mycophenolate Personalized Therapy: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology; in progress.
- A satellite symposium, Update on mycophenolate, was suggested, accepted and planned for the IATDMCT-meeting in Banff 2020. This symposium may now be suggested for the next opportunity, e.g. Rome 2021.
- To establish a course in TDM related to transplantation. This will be a course to follow online. The initiative is by D.J.A.R Moes and supported by current chair and vice chair of the ISD-SC. This project is in an early phase, and we are investigating options like integration into an already established course or to establish a new, separate course on this topic. A group of members will be recruited to develop the course. (Directors of education in the IATDMCT are informed.)
- The online forum for the IATDMCT has been discontinued. The ISD-SC is a relatively large group and some kind of forum may be useful to facilitate communication. The setup of a dedicated forum for this committee is under consideration.
Past Years' Activities Held/Committee Initiatives
See publications list below.
Publications, Scientific Contributions
- Publication in TDM Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions. Elens & al.
- Publication in TDM Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) Expert Panel. Lemaitre & al.
- Publication in Compass: Report on the symposium therapeutic drug monitoring of immunosuppressants: clinical challenges and analytical issues at the 16th congress of the Asian society of transplantation. S. Pattanaik.
- Publication in Compass: The potential of the IATDMCT Scientific Committees. S. Bergan.
Additional Committee Resources
- Biomarker Working Group (Leader U.Christans).
- Standardization of ISD TDM Working Group. (Leaders: C. Seeger, L. Langman).
Joint committee with IFCC is established.
- Intracellular tacrolimus measurement Working Group. (Leader: F. Lemaitre).
Minutes of Committee Meetings
- Minutes: Foz do Iguassu, September 24, 2019
- Minutes: Brisbane, September 17, 2018
- Minutes: Kyoto, September 26, 2017
- Minutes: Rotterdam, October 12, 2015
- Minutes: Salt Lake City, September 25, 2013